SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-022862
Filing Date
2023-06-29
Accepted
2023-06-29 09:27:47
Documents
17
Period of Report
2023-06-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34700
2 ex99-1.htm EX-99.1 3209
3 ex99-1_001.jpg GRAPHIC 524223
4 ex99-1_002.jpg GRAPHIC 584672
5 ex99-1_003.jpg GRAPHIC 681765
6 ex99-1_004.jpg GRAPHIC 513671
  Complete submission text file 0001493152-23-022862.txt   3386710

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE rnxt-20230629.xsd EX-101.SCH 3015
8 XBRL LABEL FILE rnxt-20230629_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE rnxt-20230629_pre.xml EX-101.PRE 22359
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3408
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 231054890
SIC: 2834 Pharmaceutical Preparations